Cabergoline and pleural effusion 
Cabergoline and pleural effusion Patient Reports February 12, 2012
Cabergoline Side Effects Report #5491145-6
Cabergoline side effect was reported by a Consumer or non-health professional from SPAIN on Oct 09, 2007. Male patient, 78 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, insomnia, musculoskeletal stiffness, pleural effusion, pneumonitis, serositis, skin disorder, tremor, venous stasis. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4589518-9
Cabergoline side effect was reported by a Consumer or non-health professional from on Feb 04, 2005. Female patient, 85 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, oxygen saturation decreased, pleural effusion. Cabergoline dosage: 1 MG, ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5167219-6
Cabergoline side effect was reported by a Physician from JAPAN on Nov 17, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, vomiting. Cabergoline dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5192002-5
Cabergoline side effect was reported by a Physician from JAPAN on Dec 11, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Cabergoline dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5080687-3
Cabergoline side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 81 years of age, weighting 66.36 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: hypoalbuminaemia, hypoproteinaemia, pleural effusion, pneumonia , respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with MENESIT, RABEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #5091326-X
Cabergoline side effect was reported by a Physician from JAPAN on Aug 15, 2006. Female patient, 81 years of age, weighting 66.36 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: hypoalbuminaemia, hypoproteinaemia, pleural effusion, pneumonia , respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with MENESIT, RABEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #5637425-2
Cabergoline side effect was reported by a Physician from JAPAN on Feb 13, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, parkinson's disease , pleural effusion. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5079125-6
Cabergoline side effect was reported by a Physician from JAPAN on July 27, 2006. Male patient, 79 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pneumonia aspiration, pulmonary fibrosis , tuberculous pleurisy. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PERINDOPRIL ERBUMINE, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL, POSTERISANTE. Patient was hospitalized. Patient died on 07/19/2006.Cabergoline Side Effects Report #5030687-4
Cabergoline side effect was reported by a Physician from JAPAN on June 05, 2006. Male patient, 79 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, tuberculous pleurisy. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with COVERSYL, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL, POSTERISANTE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4679992-1
Cabergoline side effect was reported by a Physician from on May 19, 2005. Male patient, 78 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, pleural effusion, pleurisy. Cabergoline dosage: unknown. During the same period patient was treated with DIOVAN, MENESIT, TOCOPHEROL. Patient recovered.Cabergoline Side Effects Report #4650054-2
Cabergoline side effect was reported by a Physician from on Apr 15, 2005. Male patient, 74 years of age, weighting 112.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea exertional, pericardial effusion, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with SENNA LEAF, HERBAL PREPARATION. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4920786-7
Cabergoline side effect was reported by a Physician from JAPAN on Feb 03, 2006. Female patient, 73 years of age, weighting 84.44 lb, was diagnosed with parkinson's disease
, reflux oesophagitis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve stenosis, blood urea increased, cardiac failure chronic, cerebral infarction, condition aggravated, face oedema, pleural effusion, reflux oesophagitis. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, EC DOPARL, SYMMETREL, ASPIRIN, ZOLPIDEM TARTRATE, LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4568054-X
Cabergoline side effect was reported by a Physician from on Jan 19, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung infiltration, pleural effusion, pleural fibrosis, right ventricular failure. Cabergoline dosage: 8 MG (8 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CLOMETHIAZOLE EDISILATE, ACETAMINOPHEN, OXYCODONE, CITALOPRAM HYDROBROMIDE, FERROUS SULPHATE, METOLAZONE, FUROSEMIDE, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4617892-3
Cabergoline side effect was reported by a Physician from on Mar 09, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, cardiac failure, dyskinesia, dyspnoea exertional, oedema peripheral, pleural effusion, weight increased. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4658886-1
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure systolic increased, cardiac failure, mitral valve prolapse, oedema peripheral, pleural effusion, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4803616-3
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Sept 12, 2005. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, pleural effusion. Cabergoline dosage: 4 MG (4 MG, QD). During the same period patient was treated with SINEMET, FLORINEF, WARFARIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4911029-9
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Feb 01, 2006. Male patient, 72 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, pleural effusion. Cabergoline dosage: 4 MG (4 MG, DAILY). During the same period patient was treated with SINEMET, FLORINEF, WARFARIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5101313-0
Cabergoline side effect was reported by a Physician from JAPAN on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration. Cabergoline dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5101366-X
Cabergoline side effect was reported by a Physician from JAPAN on Aug 21, 2006. Male patient, 71 years of age, weighting 130.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dysphagia, interstitial lung disease, lung disorder, pleural effusion, pneumonia aspiration, productive cough. Cabergoline dosage: 5 MG (0.25 MG, 4 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4870603-9
Cabergoline side effect was reported by a Physician from GERMANY on Dec 19, 2005. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, left ventricular failure, mitral valve incompetence, pleural effusion, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with LEVODOPA, AMANTADINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5073000-9
Cabergoline side effect was reported by a Physician from JAPAN on July 21, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aspiration, dysphagia, interstitial lung disease, lung disorder, pleural effusion. Cabergoline dosage: 1 MG (0.25 MG,4 IN 1 D), ORAL. During the same period patient was treated with CARBIDOPA AND LEVODOPA, GASMOTIN, ARTANE, DOPS, SYMMETREL, SELBEX, SELEGILINE HYDROCHLORIDE, NAUZELIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4635386-6
Cabergoline side effect was reported by a Physician from on Apr 01, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: apnoea, pleural effusion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4688434-1
Cabergoline side effect was reported by a Physician from on May 31, 2005. Male patient, 70 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion. Cabergoline dosage: 1MG (DAILY), ORAL; SEE IMAGE. During the same period patient was treated with SINEMET, FLORINEF, WARFARIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4587464-8
Cabergoline side effect was reported by a Physician from on Feb 02, 2005. Female patient, 69 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4614167-3
Cabergoline side effect was reported by a Physician from on Mar 03, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, pleural effusion. Cabergoline dosage: 3 MG (1 MG, 1 IN 3 D), ORAL. During the same period patient was treated with MADOPAR, TALIPEXOLE HYDROCHLORIDE, AMANTADINE, SELEGILINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4615374-6
Cabergoline side effect was reported by a Physician from on Mar 04, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG. Patient recovered.Cabergoline Side Effects Report #4629445-1
Cabergoline side effect was reported by a Physician from on Mar 23, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, parkinson's disease , pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG (4 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #5065721-9
Cabergoline side effect was reported by a Physician from JAPAN on July 12, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac failure, cardiomegaly, cardiomyopathy , pleural effusion, pneumonia , pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5072976-3
Cabergoline side effect was reported by a Physician from JAPAN on July 24, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, congestive cardiomyopathy, pleural effusion, pneumonia , pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4686452-0
Cabergoline side effect was reported by a Physician from on May 25, 2005. Male patient, 64 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pneumonia . Cabergoline dosage: 4 MG ( 2 MG, 2 IN 1 D), ORAL. Patient recovered.Cabergoline Side Effects Report #5703441-5
Cabergoline side effect was reported by a Consumer or non-health professional from SPAIN on Mar 31, 2008. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, vocal cord paralysis. Cabergoline dosage: DAILY DOSE:4MG. During the same period patient was treated with ENALAPRIL MALEATE, LEVODOPA, CARBIDOPA. Patient recovered.Cabergoline Side Effects Report #5603010-1
Cabergoline side effect was reported by a Physician from AUSTRALIA on Jan 15, 2008. Male patient, weighting 187.4 lb, was diagnosed with parkinson's disease
, restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bronchial disorder, coronary artery bypass , dyspnoea exertional, fibrosis, lung consolidation, pleural effusion, restless legs syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SINEMET CR, KARVEA, VITAMIN E, TRITACE, ZOCOR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6104206-5
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6115183-5
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6121725-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6124995-3
Cabergoline side effect was reported by a Physician from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4648761-0
Cabergoline side effect was reported by a Physician from on Apr 14, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, lung infiltration, pleural effusion, tuberculosis . Cabergoline dosage: 2 MG (2 MG, 1 IN 1 D); ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4690036-8
Cabergoline side effect was reported by a Physician from on May 31, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, heart valve insufficiency, pericarditis constrictive, pleural effusion. Cabergoline dosage: 8 MG (8 MG, DIALY), ORAL. During the same period patient was treated with MADOPAR, COMTESS, AMANTADINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4722583-4
Cabergoline side effect was reported by a Physician from AUSTRALIA on July 11, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung infiltration, pleural effusion, pleural infection, red blood cell sedimentation rate increased, tuberculosis . Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4749913-1
Cabergoline side effect was reported by a Physician from AUSTRALIA on Aug 09, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: lung infiltration, pleural effusion, pleurisy, respiratory distress, tuberculosis . Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with SINEMET, ASPIRIN, PERINDOPRIL, LASIX, LIPITOR, COLOXYL WITH SENNA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4765276-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 26, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, coronary artery disease , mitral valve incompetence, mitral valve sclerosis, pleural effusion, pneumonia , pulmonary congestion, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4821965-X
Cabergoline side effect was reported by a Physician from GERMANY on Oct 25, 2005. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chest pain , pleural effusion, white blood cell count increased. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, SIFROL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4927969-0
Cabergoline side effect was reported by a Physician from JAPAN on Feb 10, 2006. Male patient, 80 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pneumothorax. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #4931350-8
Cabergoline side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 80 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pneumothorax. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5022609-7
Cabergoline side effect was reported by a Physician from JAPAN on May 23, 2006. Male patient, 79 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion, pulmonary fibrosis
. Cabergoline dosage: unknown. During the same period patient was treated with COVERSYL, OLMETEC, LEVODOPA, SYMMETREL, NIVADIL. Patient recovered.Cabergoline Side Effects Report #4738792-4
Cabergoline side effect was reported by a Physician from GERMANY on July 22, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pericardial effusion, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with PRAMIPEXOLE. Patient recovered.
Cabergoline Side Effects Report #4759339-2
Cabergoline side effect was reported by a Physician from GERMANY on Aug 19, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pleurisy, pulmonary alveolar haemorrhage. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5509357-1
Cabergoline side effect was reported by a Pharmacist from JAPAN on Oct 26, 2007. Male patient, 48 years of age, was diagnosed with depression
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, congestive cardiomyopathy, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with RIVOTRIL, LITHIUM CARBONATE, EPADEL, TRYPTANOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5532464-4
Cabergoline side effect was reported by a Physician from JAPAN on Nov 22, 2007. Male patient, weighting 176.4 lb, was diagnosed with depression
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, congestive cardiomyopathy, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, TRYPTANOL, RIVOTRIL, EPADEL, ALOSITOL, ROHYPNOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6115216-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 02, 2009. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary hypertension
. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE, RASAGILINE. Patient recovered.